Gallia et al. also analyzed a small cohort of 38 primary GBM cases, reporting a 17% mutation rate, though they excluded some PIK3CA exons, potentially underrepresenting true mutation rates [130]. The gene discussed is PIK3CA; the disease is glioblastoma.